Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Good tolerability profile reported for tetracycline COL-3 in high-grade glioma

Dec. 5, 2002

Mercury Therapeutics licenses oncology target from Mass General

Dec. 4, 2002

Axcan receives approvable letter for Photofrin

Dec. 4, 2002

Enrollment completed in phase III trial of ABI-007

Dec. 4, 2002

Taxotere approved for first-line therapy in NSCLC

Dec. 4, 2002

Human Genome Sciences and Kirin announce license agreement

Dec. 4, 2002

Corixa withdraws dispute resolution as FDA returns Bexxar to active review status

Dec. 4, 2002

Telomerase inhibitor with potential as an antitumor and radiosensitizing agent

Dec. 4, 2002

Sulfonyhydrazine prodrug VNP-40101M advances towards phase II clinical evaluation

Dec. 4, 2002

SU-11248: preclinical and early clinical findings encourage further development

Dec. 4, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...